Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Giuliana Cassinelli, Valentina Zuco, Laura Gatti, et al.
Current Medicinal Chemistry (2013) Vol. 20, Iss. 15, pp. 1923-1945
Closed Access | Times Cited: 100

Showing 26-50 of 100 citing articles:

Development of penipanoid C-inspired 2-benzoyl-1-methyl-2,3-dihydroquinazolin-4(1H)-one derivatives as potential EGFR inhibitors: Synthesis, anticancer evaluation and molecular docking study
K. Veena, M.S. Raghu, K. Yogesh Kumar, et al.
Journal of Molecular Structure (2022) Vol. 1258, pp. 132674-132674
Closed Access | Times Cited: 25
Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development
Komal Thapa, Heena Khan, Gagandeep Kaur, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 687, pp. 149130-149130
Closed Access | Times Cited: 13
Regulation of autophagy and EMT by the interplay between p53 and RAS during cancer progression (Review)
Xiaofei Zhang, Qian Cheng, Huijing Yin, et al.
International Journal of Oncology (2017) Vol. 51, Iss. 1, pp. 18-24
Open Access | Times Cited: 46
Design, synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities
Shaimaa A. Abdelatef, Mohammed T. El‐Saadi, Noha H. Amin, et al.
European Journal of Medicinal Chemistry (2018) Vol. 150, pp. 567-578
Closed Access | Times Cited: 45
Targeted therapies in gastric cancer and future perspectives
Ozan Yazıcı
World Journal of Gastroenterology (2016) Vol. 22, Iss. 2, pp. 471-471
Open Access | Times Cited: 41
Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation
Arnatchai Maiuthed, Narumol Bhummaphan, Sudjit Luanpitpong, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 35, pp. 13534-13552
Open Access | Times Cited: 41
Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold
Mohammed S. Abdel‐Maksoud, Usama M. Ammar, Chang‐Hyun Oh
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 10, pp. 2041-2051
Closed Access | Times Cited: 41
miR-125b inhibits keratinocyte proliferation and promotes keratinocyte apoptosis in oral lichen planus by targeting MMP-2 expression through PI3 K/Akt/mTOR pathway
Jing Wang, Hong Luo, Yan Xiao, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 80, pp. 373-380
Closed Access | Times Cited: 40
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Cristina Corno, Laura Gatti, Cinzia Lanzi, et al.
Current Medicinal Chemistry (2016) Vol. 23, Iss. 15, pp. 1496-1512
Open Access | Times Cited: 40
Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives
Eman S. Nossier, Somaia S. Abd El‐Karim, Nagy M. Khalifa, et al.
Molecules (2018) Vol. 23, Iss. 12, pp. 3074-3074
Open Access | Times Cited: 38
An Activatable Nano‐Prodrug for Treating Tyrosine‐Kinase‐Inhibitor‐Resistant Non‐Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging
Xin Xie, Chenyue Zhan, Jie Wang, et al.
Small (2020) Vol. 16, Iss. 38
Closed Access | Times Cited: 33
Synthesis, characterization and bioactivity of new pyridine-2(H)-one, nicotinonitrile, and furo[2,3-b]pyridine derivatives
Mohammad Ibrahim, Mohamad Nurul Azmi, Maram B. Alhawarri, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 4
4(3H)-Quinazolinone: A Natural Scaffold for Drug and Agrochemical Discovery
Ke Chen, Shumin Wang, Shuyue Fu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2473-2473
Open Access
High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma
Maqbool Ahmed, Azhar R. Hussain, Prashant Bavi, et al.
Carcinogenesis (2014) Vol. 35, Iss. 7, pp. 1564-1572
Open Access | Times Cited: 39
PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression
Huijuan Wu, Ke Wang, Wenxin Liu, et al.
Biochemical and Biophysical Research Communications (2014) Vol. 444, Iss. 2, pp. 141-146
Closed Access | Times Cited: 36
Mammalian Sterile20-like Kinases: Signalings and Roles in Central Nervous System
Sheng Chen, Yuanjian Fang, Shenbin Xu, et al.
Aging and Disease (2018) Vol. 9, Iss. 3, pp. 537-537
Open Access | Times Cited: 33
Natural resorcylic acid lactones: A chemical biology approach for anticancer activity
Shilpa Kuttikrishnan, Kirti S. Prabhu, Ahmed H. Al Sharie, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 547-557
Open Access | Times Cited: 25
Activated Akt/mTOR-autophagy in local T cells of oral lichen planus
Na Zhang, Jing Zhang, Ya‐Qin Tan, et al.
International Immunopharmacology (2017) Vol. 48, pp. 84-90
Closed Access | Times Cited: 32
Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells
Giacomo Cossa, Cinzia Lanzi, Giuliana Cassinelli, et al.
Cancer Letters (2014) Vol. 347, Iss. 2, pp. 212-224
Closed Access | Times Cited: 30
Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells
Vladislav S. Golubkov, Alex Y. Strongin
Cell Communication and Signaling (2014) Vol. 12, Iss. 1, pp. 15-15
Open Access | Times Cited: 30
Effects of Astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway
Xiaoqing Zhang, Chang Yao, Weihe Bian, et al.
Food Science & Nutrition (2019) Vol. 7, Iss. 11, pp. 3403-3413
Open Access | Times Cited: 29
Cannabinol inhibits cell growth and triggers cell cycle arrest and apoptosis in cancer cells
Nuanying Zhong, Dongping Li, Bo Wang, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 48, pp. 102627-102627
Closed Access | Times Cited: 8
Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors
Ankush Kumar, Bhupinder Kumar, Rohit Bhatia
Assay and Drug Development Technologies (2023) Vol. 21, Iss. 5, pp. 222-233
Closed Access | Times Cited: 8
Killing Me Softly—Future Challenges in Apoptosis Research
Mike‐Andrew Westhoff, Oliver Brühl, Lisa Nonnenmacher, et al.
International Journal of Molecular Sciences (2014) Vol. 15, Iss. 3, pp. 3746-3767
Open Access | Times Cited: 28
Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases
Giuliana Cassinelli, Laura Dal Bo, Enrica Favini, et al.
Cancer Letters (2017) Vol. 415, pp. 187-197
Closed Access | Times Cited: 28

Scroll to top